Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria

Nephrol Dial Transplant. 2008 Apr;23(4):1103-6. doi: 10.1093/ndt/gfl756. Epub 2007 Jan 8.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Albuminuria / diagnosis*
  • Albuminuria / economics
  • Albuminuria / epidemiology
  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / economics
  • Diabetic Nephropathies / drug therapy
  • Diabetic Nephropathies / economics
  • Diabetic Nephropathies / etiology
  • Economics, Pharmaceutical / trends*
  • Humans
  • Nephrology / economics*
  • Prognosis